LH: The Pituitary Pulse That Drives Ovulation and Testosterone
Luteinizing hormone (LH) is a chemical messenger made in the front part of the pituitary gland in the brain (anterior pituitary). Its release is prompted by signals from the hypothalamus (gonadotropin-releasing hormone, GnRH). LH is a glycoprotein produced by specialized pituitary cells (gonadotrophs). An LH blood test measures how much of this messenger is circulating at the moment of the draw, offering a snapshot of the brain's signal to the ovaries or testes.
LH's core job is to drive sex hormone production and key steps in reproduction. In people with ovaries, a sharp rise in LH triggers ovulation and transforms the follicle into the corpus luteum, which makes progesterone; LH also stimulates theca cells to make androgens used to build estrogen. In people with testes, LH stimulates Leydig cells to produce testosterone. Working alongside follicle-stimulating hormone (FSH), LH reflects the activity of the hypothalamic–pituitary–gonadal axis (HPG), linking brain signals to hormone output and the maturation of eggs or sperm.
Why LH Sits at the Top of the Reproductive Axis
Luteinizing hormone (LH) is the pituitary signal that tells the ovaries or testes when to make sex hormones and, in women, when to release an egg. Because it sits at the top of the reproductive axis, LH links brain signaling with fertility, menstrual function, testosterone/estrogen balance, bone health, mood, and metabolism.
Through its control of sex steroids, LH influences fertility, bone and muscle maintenance, metabolic rate, cardiovascular risk factors, mood, and cognition. It reflects the health of the hypothalamic–pituitary–gonadal (HPG) axis and is naturally pulsatile; in menstruating women it varies by cycle phase.
Low, Mid-Cycle, and High LH — Reading the Pattern
Reference ranges are lab- and age-specific. In men, values are usually steady within a narrow low-to-mid range. In premenopausal women, LH is low in the follicular phase, peaks sharply at mid-cycle to trigger ovulation, then falls in the luteal phase; after menopause it stays higher. Outside the ovulatory surge, "within reference ranges" tends to sit in the mid-range for one's sex, age, and cycle phase.
When LH is low for context, it often reflects reduced hypothalamic or pituitary drive (secondary hypogonadism). Men may notice low libido, fatigue, infertility, reduced muscle and bone. Women may see absent or irregular periods and anovulation. Teens can have delayed puberty. Pregnancy naturally suppresses LH. Chronic stress, high prolactin, severe illness, and certain hormones or opioids can lower it.
Low values usually reflect reduced pituitary drive or strong negative feedback from high sex-steroid exposure. This occurs with hypothalamic or pituitary suppression (stress, low energy availability, hyperprolactinemia) or with pregnancy and estrogen/progestin contraception. In women it associates with missed or irregular periods and low estradiol; in men with low testosterone, low sperm output, fatigue, and reduced muscle. In youth, low-for-age can signal delayed puberty.
Being in range suggests intact HPG-axis signaling and appropriate feedback. In men, LH is relatively stable and mid-range typically aligns with normal testosterone production. In premenopausal women, values vary by cycle, with a brief mid-cycle surge; outside the surge, mid-range values usually indicate regular ovulation and balanced estrogen/progesterone support for bone, body composition, and mood.
When LH is high, it often signals that the gonads aren't responding (primary ovarian or testicular failure), so the pituitary pushes harder. Men may have low testosterone with infertility and hot flashes; women may have irregular cycles, menopausal symptoms, or anovulation; LH is characteristically high at menopause and can be elevated in PCOS. In children, high LH may indicate central precocious puberty.
High values usually reflect reduced gonadal feedback from primary gonadal dysfunction. In women this includes primary ovarian insufficiency and menopause; polycystic ovary syndrome can show a higher LH-to-FSH pattern in some, though not all. In men, elevated LH with low testosterone suggests primary testicular failure. High-for-age in children can indicate early puberty.
What Can Shift a Single LH Measurement
Interpretation depends on age, sex, menstrual cycle day, and pregnancy. LH is pulsatile; single measurements can vary. Estrogens, progestins, GnRH analogs, anabolic steroids, and opioids lower LH; menopause raises it. Pairing LH with FSH and estradiol or testosterone improves context.
Reading LH With FSH, Estradiol or Testosterone, and Prolactin
Big picture: LH is a window into the hypothalamic-pituitary-gonadal axis. Interpreting it alongside FSH, estradiol or testosterone, prolactin, and thyroid tests clarifies causes of infertility, cycle symptoms, sexual health concerns, and bone risks, and it informs long-term metabolic and cardiovascular health planning.
FAQs
LH testing is a blood test that measures LH to assess pituitary–gonadal signaling, ovulation timing, and support for testosterone production.
Testing LH helps map ovulation, characterize cycle patterns, clarify causes of low testosterone, and track how training stress, energy availability, and age affect reproductive hormones.
Frequency depends on your goals: for ovulation tracking, test near mid-cycle and around the expected surge; for baseline assessment, test in a consistent cycle phase or at regular intervals to monitor trends.
Menstrual cycle phase, age, stress, heavy training, low energy availability, chronic illness, and medications such as hormonal contraception, testosterone therapy, GnRH analogs, and SERMs can shift LH.
Fasting is typically not required. For menstruating individuals, timing matters—testing mid-cycle helps detect the LH surge; testing in a consistent phase aids comparison over time.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Marques, P., De Sousa Lages, A., Skorupskaite, K., Rozario, K. S., Anderson, R. A., & George, J. T. (2024). Physiology of GnRH and gonadotrophin secretion. In Endotext. MDText.com. https://www.ncbi.nlm.nih.gov/books/NBK279070/
- Casteel, C. O., & Singh, G. (2023). Physiology, gonadotropin-releasing hormone. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558992/
- Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause, 19(4), 387-395. https://doi.org/10.1097/gme.0b013e31824d8f40
- Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., Norman, R. J., Mousa, A., & Joham, A. E. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility, 120(4), 767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
- Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007). Position statement: Utility, limitations, and pitfalls in measuring testosterone: An Endocrine Society position statement. The Journal of Clinical Endocrinology & Metabolism, 92(2), 405-413. https://doi.org/10.1210/jc.2006-1864






































.avif)
